ProText™ is the first and only connective tissue supplement derived from the umbilical cord that has been recognized as a 361 HCT/P by any government body. Our new dual-layer amniotic membrane product, AmnioText Patch, was also awarded a Q-Code from CMS and is now available to your patients.
Click below to view our CMS Decision Summaries.Download
ProText™ is our most concentrated Wharton’s jelly allograft. This connective tissue supplement provides the scaffolding necessary to replace missing or damaged tissue with an abundance of structural proteins, cytokines, and growth factors.
AmnioText™ Patch is a sterile, dehydrated human amniotic membrane allograft, intended for homologous use to cover and protect the recipient’s tissues. It is minimally manipulated and processed to preserve the original relevant characteristics relating to its utility as a barrier.